Back to RTW INVESTMENTS, LP

PTGX
Showing 8 of 27 quarters

Position history for RTW INVESTMENTS, LP's holdings in PROTAGONIST THERAPEUTICS INC

RTW INVESTMENTS, LP holds 5.1M shares of PTGX (PROTAGONIST THERAPEUTICS INC), worth $533.2M as of 2026-Q1. PTGX represents 5.3% of RTW INVESTMENTS, LP's portfolio.

Current Value

$533.2M

Current Shares

5.1M

Total Value Change

+$350.1M

Total Shares Change

-227,351

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Unchanged
5.1M
0.0%
$533.2M5.3%$91.30
0
2025-Q4
Decreased
5.1M
-12.1%
$441.9M4.4%$87.26
0
2025-Q3
Unchanged
5.8M
0.0%
$382.4M4.7%$65.14
0
2025-Q2
Increased
5.8M
+0.6%
$318.1M4.5%$55.69
57
2025-Q1
Increased
5.7M
+4.0%
$276.6M4.2%$48.88
59
2024-Q4
Increased
5.5M
+1.3%
$212.2M3.2%$38.51
57
2024-Q3
Increased
5.4M
+2.6%
$244.2M3.5%$44.56
58
2024-Q2
Decreased
5.3M
-0.6%
$183.2M2.8%$34.65
0

Other major holders of PTGX: BlackRock, Inc., FARALLON CAPITAL MANAGEMENT, L.L.C., UBS Group AG

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used